arGEN-X SE ADR (ARGX): Price and Financial Metrics
ARGX Price/Volume Stats
| Current price | $640.52 | 52-week high | $678.21 |
| Prev. close | $659.81 | 52-week low | $349.86 |
| Day low | $639.78 | Volume | 485,300 |
| Day high | $661.22 | Avg. volume | 312,882 |
| 50-day MA | $617.52 | Dividend yield | N/A |
| 200-day MA | $501.52 | Market Cap | 38.67B |
ARGX Stock Price Chart Interactive Chart >
arGEN-X SE ADR (ARGX) Company Bio
argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancers, today announced its 2021 corporate priorities and highlighted recent achievements from its late-stage immunology pipeline driven by its FcRn antagonist, efgartigimod. Additionally, the Company announced interim data from the Phase 2 CULMINATE trial of cusatuzumab in development with Cilag GmbH International, an affiliate of Janssen, and provided financial guidance for 2021. (Source:Wiki)
ARGX Price Returns
| 1-mo | 2.68% |
| 3-mo | 14.80% |
| 6-mo | 31.70% |
| 1-year | 75.71% |
| 3-year | 129.37% |
| 5-year | 329.22% |
| YTD | 4.15% |
| 2024 | 61.66% |
| 2023 | 0.42% |
| 2022 | 8.18% |
| 2021 | 19.08% |
| 2020 | 83.21% |
Continue Researching ARGX
Want to do more research on Argenx Se's stock and its price? Try the links below:Argenx Se (ARGX) Stock Price | Nasdaq
Argenx Se (ARGX) Stock Quote, History and News - Yahoo Finance
Argenx Se (ARGX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...